Clyde Biosciences’ CellOPTIQ Superior to MEA

Posted on Leave a commentPosted in Uncategorized

Clyde Biosciences is delighted to announce that its CellOPTIQ system has demonstrated superiority over the MEA system. In the major landmark CiPA study, CellOPTIQ was put up against the legacy MEA system and CellOPTIQ demonstrated greater sensivity and predictiveness when compared to the MEA. Clyde’s proprietary system recorded the expected effect on 95% of the […]

Clyde Biosciences Nominated for Top Award

Posted on Leave a commentPosted in Uncategorized

The Clyde Biosciences team are delighted to have been shortlisted for an award in February’s Scottish Life Sciences Awards. One of three finalists in the Innovative Collaboration award, Clyde has been recognised for its contribution to a global initiative designed to improve the way drugs are assessed for cardiac safety. The initiative, known as CiPA […]

Clyde Recognised as Leading Innovator

Posted on Leave a commentPosted in Uncategorized

Clyde Biosciences has been recognised in The Scotsman newspaper (December 1, 2017) as a leading innovator in Scottish life sciences. Alongside other Scottish companies, Clyde was noted for its recent project with AstraZeneca examining the effects of certain drug compounds on cardiac cells. Clyde’s unique optical cell function assay service provides information to biotech and […]

Clyde Biosciences SPS Poster Downloads

Posted on Leave a commentPosted in Uncategorized

Highlights Clyde Biosciences were delighted to present a total of four posters at the recent SPS meeting in Berlin, representing collobarations with major pharmaceutical companies. The posters showed: The influence of fibroblast co-culture and 3D structures on cardiac action potentials of human stem cell derived cardiomyocytes (Collaboration with Abbvie) AbbVie SPS FINAL Measurements of voltage, intracellular […]

SPS 2017 Posters

Posted on Leave a commentPosted in Uncategorized

Clyde Biosciences Presents Four Posters at SPS 2017 Highlights Clyde Biosciences were delighted to present a total of four posters at the recent SPS meeting in Berlin, representing collobarations with major pharmaceutical companies. The posters showed: The influence of fibroblast co-culture and 3D structures on cardiac action potentials of human stem cell derived cardiomyocytes (Collaboration […]

Groundbreaking Research Into Kinases Using CellOPTIQ From Clyde Biosciences

Posted on Leave a commentPosted in Uncategorized

Recent Publication Highlights Flexibility and Power of Clyde’s CellOPTIQ® Assay Highlights Collaboration with AZ on kinase inhibitor induced cardiotoxicity Understanding E-C coupling is essential in kinase research CellOPTIQ® is the only single mechanistic screen providing insight into E-C coupling mechanism Observing the interplay between voltage, calcium transient and contractility is vital and is only available […]

Clyde Biosciences

Clyde Biosciences Autumn Business Update

Posted on Leave a commentPosted in news

Clyde Biosciences Autumn Business Update Highlights CiPA 28 study finished and data submitted weeks ahead of schedule New CellOPTIQ®-X contractility assay launched New Heart Failure model launched Clyde Biosciences today announces progress in its autumn business update. The company reports that in the last three months it has completed work on a number of important […]

Clyde Biosciences

Clyde Launches New Contractility Service – CellOPTIQ®-X

Posted on Leave a commentPosted in news

NEWHOUSE – Clyde Biosciences today announced the launch of a new service to serve the needs of its global pharma clients. CellOPTIQ®-X represents a revolution in contractility assays, offering: Early detection of contractility toxicities Higher throughput, cost-effective solution Reduction in animal requirements Accurate prediction of the human response Reduction in later stage attrition Heart cell […]

Alan Johnston

Clyde Appoints New Chair

Posted on Leave a commentPosted in news

Clyde Biosciences is delighted to announce the appointment of Alan Johnston to the post of Chair. Alan brings a wealth of CRO experience to Clyde. He spent some 30 years with Inveresk Research (subsequently Charles River Laboratories) in Edinburgh, Alan had several Senior Management posts within Inversek and had responsibility for Commercial staff. He is now Trustee […]